These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 34481517

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegol.
    Maksymowych WP, Kumke T, Auteri SE, Hoepken B, Bauer L, Rudwaleit M.
    Arthritis Res Ther; 2021 Oct 29; 23(1):274. PubMed ID: 34715908
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.
    Lopalco G, Venerito V, Cantarini L, Emmi G, Salaffi F, Di Carlo M, Tafuri S, Gentileschi S, Di Scala G, Nivuori M, Cacciapaglia F, Galeazzi M, Lapadula G, Iannone F.
    Clin Exp Rheumatol; 2019 Oct 29; 37(5):762-767. PubMed ID: 31025925
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational study.
    Christiansen SN, Horskjær Rasmussen S, Ostergaard M, Pons M, Michelsen B, Pavelka K, Codreanu C, Ciurea A, Glintborg B, Santos MJ, Sari I, Rotar Z, Gudbjornsson B, Macfarlane GJ, Relas H, Iannone F, Laas K, Wallman JK, van de Sande M, Provan SA, Castrejon I, Zavada J, Mogosan C, Nissen MJ, Loft AG, Barcelos A, Erez Y, Pirkmajer KP, Grondal G, Jones GT, Hokkanen AM, Chimenti MS, Vorobjov S, Di Giuseppe D, Kvien TK, Otero-Varela L, van der Horst-Bruinsma I, Hetland ML, Ørnbjerg LM.
    RMD Open; 2024 Jul 24; 10(3):. PubMed ID: 39053949
    [Abstract] [Full Text] [Related]

  • 8. MRI contributes to accurate and early diagnosis of non-radiographic HLA-B27 negative axial spondyloarthritis.
    Lu CC, Huang GS, Lee TS, Chao E, Chen HC, Guo YS, Chu SJ, Liu FC, Kao SY, Hou TY, Chen CH, Chang DM, Lyu SY.
    J Transl Med; 2021 Jul 09; 19(1):298. PubMed ID: 34243762
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Partial remission in ankylosing spondylitis and non-radiographic axial spondyloarthritis in treatment with infliximab plus naproxen or naproxen alone: associations between partial remission and baseline disease characteristics.
    Sieper J, Rudwaleit M, Lenaerts J, Wollenhaupt J, Myasoutova L, Park SH, Song YW, Yao R, Huyck S, Govoni M, Chitkara D, Vastesaeger N.
    Rheumatology (Oxford); 2016 Nov 09; 55(11):1946-1953. PubMed ID: 27411482
    [Abstract] [Full Text] [Related]

  • 11. Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a randomized, double-blind phase 3 study, MEASURE 3.
    Pavelka K, Kivitz A, Dokoupilova E, Blanco R, Maradiaga M, Tahir H, Pricop L, Andersson M, Readie A, Porter B.
    Arthritis Res Ther; 2017 Dec 22; 19(1):285. PubMed ID: 29273067
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of secukinumab in Asian patients with active ankylosing spondylitis: 52-week pooled results from two phase 3 studies.
    Wei JC, Baeten D, Sieper J, Deodhar A, Bhosekar V, Martin R, Porter B.
    Int J Rheum Dis; 2017 May 22; 20(5):589-596. PubMed ID: 28544533
    [Abstract] [Full Text] [Related]

  • 13. Clinical significance of possible HLA biomarkers in axial spondyloarthritis beyond HLA-B27 positivity.
    Šegota A, Schnurrer-Luke-Vrbanić T, Avancini-Dobrović V, Mirić F.
    Rheumatol Int; 2023 Nov 22; 43(11):2073-2079. PubMed ID: 37450032
    [Abstract] [Full Text] [Related]

  • 14. Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi.
    Malaviya AN, Kalyani A, Rawat R, Gogia SB.
    Int J Rheum Dis; 2015 Sep 22; 18(7):736-41. PubMed ID: 26172961
    [Abstract] [Full Text] [Related]

  • 15. The role of LCN2 and LCN2-MMP9 in spondylitis radiographic development: gender and HLA-B27 status differences.
    Tsui FWL, Lin A, Sari I, Zhang Z, Pritzker KPH, Tsui HW, Inman RD.
    Arthritis Res Ther; 2022 Jul 08; 24(1):164. PubMed ID: 35804445
    [Abstract] [Full Text] [Related]

  • 16. Is the current ASAS expert definition of a positive family history useful in identifying axial spondyloarthritis? Results from the SPACE and DESIR cohorts.
    Ez-Zaitouni Z, Hilkens A, Gossec L, Berg IJ, Landewé R, Ramonda R, Dougados M, van der Heijde D, van Gaalen F.
    Arthritis Res Ther; 2017 May 31; 19(1):118. PubMed ID: 28569222
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the nonsteroidal anti-inflammatory drug-sparing effect of etanercept in axial spondyloarthritis: results of the multicenter, randomized, double-blind, placebo-controlled SPARSE study.
    Dougados M, Wood E, Combe B, Schaeverbeke T, Miceli-Richard C, Berenbaum F, Koppiker N, Dubanchet A, Logeart I.
    Arthritis Res Ther; 2014 Nov 27; 16(6):481. PubMed ID: 25428762
    [Abstract] [Full Text] [Related]

  • 18. Efficiency of treatment with non-steroidal anti-inflammatory drugs according to current recommendations in patients with radiographic and non-radiographic axial spondyloarthritis.
    Baraliakos X, Kiltz U, Peters S, Appel H, Dybowski F, Igelmann M, Kalthoff L, Krause D, Menne HJ, Saracbasi-Zender E, Schmitz-Bortz E, Vigneswaran M, Braun J.
    Rheumatology (Oxford); 2017 Jan 27; 56(1):95-102. PubMed ID: 27997346
    [Abstract] [Full Text] [Related]

  • 19. HLA-B27 as a predictor of effectiveness of treatment with TNF inhibitors in axial spondyloarthritis: data from the Swiss Clinical Quality Management Registry.
    Fröhlich F, Micheroli R, Hebeisen M, Kissling S, Bürki K, Exer P, Bräm R, Niedermann K, Möller B, Nissen MJ, Kyburz D, Andor M, Distler O, Scherer A, Ciurea A.
    Clin Rheumatol; 2023 May 27; 42(5):1267-1274. PubMed ID: 36574181
    [Abstract] [Full Text] [Related]

  • 20. 5-year efficacy and safety of secukinumab in patients with ankylosing spondylitis: end-of-study results from the phase 3 MEASURE 2 trial.
    Marzo-Ortega H, Sieper J, Kivitz AJ, Blanco R, Cohen M, Pavelka K, Delicha EM, Stefanska A, Richards HB, Rohrer S.
    Lancet Rheumatol; 2020 Jun 27; 2(6):e339-e346. PubMed ID: 38273597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.